title: Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.
authors.forename: Gil I
authors.initials: GI
authors.lastname: Wolfe
authors.forename: Sharon P
authors.initials: SP
authors.lastname: Nations
authors.forename: Dennis K
authors.initials: DK
authors.lastname: Burns
authors.forename: Laura L
authors.initials: LL
authors.lastname: Herbelin
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Barohn
mesh_terms: D000328:Adult; D020274:Autoimmune Diseases of the Nervous System / Q000235:genetics / Q000628:therapy*; D005260:Female; D020234:Gait Ataxia / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011115:Polyneuropathies / Q000209:etiology* / Q000628:therapy; D012074:Remission Induction; D012678:Sensation Disorders / Q000209:etiology* / Q000628:therapy; D012859:Sjogren's Syndrome / Q000150:complications / Q000235:genetics / Q000628:therapy*
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents